International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 693-700 , 1 March 2008

Has the Pattern of Practice in the Prescription of Radiotherapy for the Palliation of Thoracic Symptoms Changed Between 1999 and 2006 at the Rapid Response Radiotherapy Program?

  • Alysa Fairchild, M.D., F.R.C.P.C.

      Affiliations

    • Rapid Access Palliative Radiotherapy Program, Cross Cancer Institute, Edmonton, Alberta, Canada
    • ,
  • Philiz Goh, B.Sc.

      Affiliations

    • Rapid Response Radiotherapy Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Emily Sinclair, B.Sc., M.R.T.(T).

      Affiliations

    • Rapid Response Radiotherapy Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Elizabeth A. Barnes, M.D., F.R.C.P.C.

      Affiliations

    • Rapid Response Radiotherapy Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Sunita Ghosh, Ph.D.(C)

      Affiliations

    • Department of Experimental Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada
    • ,
  • Cyril Danjoux, M.D., F.R.C.P.C.

      Affiliations

    • Rapid Response Radiotherapy Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Lisa Barbera, M.D., M.Sc., F.R.C.P.C.

      Affiliations

    • Rapid Response Radiotherapy Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • May Tsao, M.D., F.R.C.P.C.

      Affiliations

    • Rapid Response Radiotherapy Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • ,
  • Edward Chow, M.B.B.S., Ph.D., F.R.C.P.C.

      Affiliations

    • Rapid Response Radiotherapy Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
    • Corresponding Author InformationReprint requests to: Edward Chow, M.B.B.S., Ph.D., F.R.C.P.C., Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5. Tel: (416) 480-4998; Fax: (416) 480-6002

Received 15 September 2007 ,Revised 27 October 2007 ,Accepted 30 October 2007.

References 

  1. Hoegler D. Radiotherapy for palliation of symptoms in incurable cancer. Curr Probl Cancer. 1997;21:129–183
  2. Coia LR, Hanks GE, Martz K, et al. Practice patterns of palliative care for the United States 1984–1985. Int J Radiat Oncol Biol Phys. 1988;14:1261–1269
  3. Okawara G, Mackay JA, Evans WK, et al. Management of unresected stage III NSCLC: A systematic review. J Thorac Oncol. 2006;1:377–393
  4. Brundage MD, Bezjak A, Dixon P, et al. The role of palliative thoracic radiotherapy in non-small cell lung cancer. Can J Oncol. 1996;6(Suppl 1):25–32
  5. Sirzen F, Kjellen E, Sorenson S, et al. A systematic overview of radiation therapy effects in non-small cell lung cancer. Acta Oncol. 2003;42:493–515
  6. Langendijk J, Ten Velde G, Aaronson N, et al. Quality of life after palliative radiotherapy in non-small cell lung cancer: A prospective study. Int J Radiat Oncol Biol Phys. 2000;47:149–155
  7. MRC Lung Cancer Working Party. Inoperable non-small-cell lung cancer (NSCLC) . A Medical Research Council randomized trial of palliative radiotherapy with two fractions or ten fractions. Br J Cancer. 1991;63:265–270
  8. MRC Lung Cancer Working Party . A Medical Research Council (MRC) randomized trial of palliative radiotherapy with two fractions of a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Br J Cancer. 1992;65:934–941
  9. Abratt RP, Shepherd LJ, Mameena Salton DG. Palliative radiation for stage 3 non-small cell lung cancer: A prospective study of two moderately high dose regimens. Lung Cancer. 1995;13:137–143
  10. MRC Lung Cancer Working Party . Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Clin Oncol (R Coll Radiol). 1996;8:167–175
  11. Rees GJG, Devrell CE, Barley VL, et al. Palliative radiotherapy for lung cancer: Two versus five fractions. Clin Oncol (R Coll Radiol). 1997;9:90–95
  12. Nestle U, Nieder C, Walter K, et al. A palliative accelerated irradiation regimen for advanced non-small-cell lung cancer vs. conventionally fractionated 60Gy: Results of a randomized equivalence study. Int J Radiat Oncol Biol Phys. 2000;48:95–103
  13. Bezjak A, Dixon P, Brundage M, et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15). Int J Radiat Oncol Biol Phys. 2002;54:719–728
  14. Sundstrom S, Bremnes R, Aasebo U, et al. Hypofractionated palliative radiotherapy (17Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial. J Clin Oncol. 2004;22:801–810
  15. Erridge SC, Gaze MN, Price A, et al. Symptom control and quality of life in people with lung cancer: A randomized trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol). 2005;17:61–67
  16. Kramer GW, Wanders SL, Noordijk EM, et al. Results of the Dutch national study of the palliative effect of irradiation using two different treatment schemes for non-small-cell lung cancer. J Clin Oncol. 2005;23:2962–2970
  17. Senkus-Konefka E, Dziadziuszko , Bednaruk-Mlynski E, et al. A prospective, randomized study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC). Br J Cancer. 2005;92:1038–1045
  18. Toy E, Macbeth F, Coles B, et al. Palliative thoracic radiotherapy for non-small-cell lung cancer: A systematic review. Am J Clin Oncol (CCT). 2003;26:112–120
  19. Lester JF, Macbeth FR, Toy E, et al. Palliative radiotherapy regimens for non-small-cell lung cancer. Cochrane Database of Systematic Reviews. 2006;Issue 4. Art. No.: CD002143
  20. Duncan G, Duncan W, Maher EJ. Patterns of palliative radiotherapy in Canada. Clin Oncol (R Coll Radiol). 1993;5:92–97
  21. American Society of Clinical Oncology . Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol. 1997;15:2996–3018
  22. Timothy AR, Girling DJ, Saunders MI, et al. Consensus statement: Radiotherapy for inoperable lung cancer. Clin Oncol (R Coll Radiol). 2001;13:86–87
  23. Scottish Intercollegiate Guidelines Network. Management of patients with lung cancer: A national clinical guideline. Available at: http://www.sign.ac.uk/pdf/sign80.pdf. Accessed October 25, 2007.
  24. Tjan-Heijnen VC, Groen HJ, Schramel FM, et al. Consensus conference on palliative treatment of stage IV NSCLC. Neth J Med. 2001;58:52–61
  25. BC Cancer Agency Cancer Management Guidelines. Non-small cell lung cancer. Available at: http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Lung/6ManagementPolicies/641NonSmallCellLungCancer/13UnresectableNSCLCTreatedwithPalliativeIntent.htm. Accessed October 25, 2007.
  26. National Comprehensive Cancer Network. Treatment guidelines. NCCN Clinical Practice Guidelines in Oncology Non-Small Cell Lung Cancer V.2.2008 page. Available at: http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf. Accessed October 25, 2007.
  27. Danjoux C, Chow E, Drossos A, et al. An innovative rapid response radiotherapy program to reduce waiting times for palliative radiotherapy. Support Care Cancer. 2006;14:38–43
  28. Dixon P. Palliative radiotherapy in Canada. Can J Oncol. 1996;6(Suppl 1):74–83
  29. Maher EJ, Coia L, Duncan G, et al. Treatment strategies in advanced and metastatic cancer: Differences in attitude between the USA, Canada and Europe. Int J Radiat Oncol Biol Phys. 1992;23:239–244
  30. Williams MV, James ND, Summers ET, et al. National survey of radiotherapy fractionation practice in 2003. Clin Oncol (R Coll Radiol). 2006;18:3–14
  31. Priestman TJ, Bullimore JA, Godden TP, et al. The Royal College of Radiologists' fractionation survey. Clin Oncol (R Coll Radiol). 1989;1:39–46
  32. Holloway L. Current practice when treating lung cancer in Australasia. Australas Radiol. 2007;51:62–67
  33. Tang JI, Back MF, Mukherjee R, et al. Patient preference for radiotherapy fractionation schedule in the palliation of symptomatic unresectable lung cancer. [Abstract] Int J Radiat Oncol Biol Phys. 2006;66(Suppl 1):S137
  34. Timothy A. Treatment for lung cancer: Who decides?. Clin Oncol (R Coll Radiol). 1993;5:69–70
  35. Bradley NM, Husted J, Sey MS, et al. Review of patterns of practice and patients' preferences in the treatment of bone metastases with palliative radiotherapy. Support Care Cancer. 2007;15:373–385
  36. Hartsell W, Shah A, Graney M, et al. Palliation of bone metastases in the USA: A survey of patterns of practice. [Abstract 45] Support Care Cancer. 1998;6:175
  37. Ben-Josef E, Shamsa F, Williams AO, et al. Radiotherapeutic management of osseous metastases: A survey of current patterns of care. Int J Radiat Oncol Biol Phys. 1998;40:915–921
  38. Gupta T, Sarin R. Palliative radiation therapy for painful vertebral metastases—a practice survey. Cancer. 2004;101:2892–2896
  39. Lawton PA, Maher EJ. Treatment strategies for advanced and metastatic cancer in Europe. Radiother Oncol. 1991;22:1–6
  40. Franklin C, Poulsen M. How do waiting times affect radiation dose fractionation schedules?. Australas Radiol. 2000;44:428–432

 Presented in part in poster form at the 20th International Symposium of Supportive Care in Cancer, June 27–30, 2007, St Gallen, Switzerland.

 This project was generously supported by the Michael and Karen Goldstein Cancer Research Fund. Dr. Barbera is supported by a Career Scientist Award from the Ontario Ministry of Health and Long Term Care.

 Conflict of interest: none.

PII: S0360-3016(07)04463-X

doi: 10.1016/j.ijrobp.2007.10.046

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 3 , Pages 693-700 , 1 March 2008

Article Tools

* Image Usage & Resolution